Rachel Sanborn works in the field of Oncology. She went to University of Illinois College of Medicine at Chicago. University of Illinois College of Medicine at Chicago is ranked 49/85 in Research/PrimaryCare. She received awards:"CMS Meaningful Use Stage 1 Certification". Dr. Rachel E. Sanborn is also a published MD. She has 11 publication published. The most recent publication is: Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Study of the Efficacy and Safety of Apricoxib in Combination With Either Docetaxel or Pemetrexed in ...
NPI NUMBER | 1275548794 | |
NPPES Provider LastName | SANBORN | |
NPPES Provider FirstName | RACHEL | |
NPPES Provider ZIPCode | 972132933 | |
NPPES Provider State | OR | |
Specialty Description | Medical Oncology | |
Total Claim Count | 430.0 | |
Distinct Opioid Count | 1.0 | |
Opioid Claim Count | 20.0 | |
Percent Opioid Claims | 4.65 |
National Provider Identifier [NPI] | 1275548794 |
Last Name Of The Provider | SANBORN |
First Name Of The Provider | RACHEL |
View All |
Dr. Julie N. Graff, MD
This Doctor is OpenDoctor Recommended. This doctor has more publications |
|
Dr. John W. Smith, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Alison K. Conlin, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Tarunpreet Bains, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Robert J. Raish, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Walter J. Urba, MD
This Doctor is OpenDoctor Recommended. This doctor has more publications |
|
Dr. Joshi J. Alumkal, MD
This Doctor is OpenDoctor Recommended. This doctor has more publications |
|
Dr. Kathleen M. Ogle, MD |